RLYB (rallybio.com) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Rallybio (RLYB)

Rallybio Corporation (RLYB) is betting on the internal growth of orphan drug development without mergers, which has triggered momentum in the company's current forward P/E. The mark 0.00 serves as the current indicator for this metric. High authority in neonatal rescue supports the share price, however, geopolitical disruptions in biomaterial logistics create serious risks for the global implementation of new drugs.

Rallybio Corporation - Rasio kapitalisasi marang bathi mangsa ngarep RLYB (periode 04.07.2022 - 16.11.2026)

Ringkesan rincian data analitis rallybio.com (RLYB)

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental:RLYB Rallybio Corporation
Produk merek Rallybio Corporation

The forward P/E compares the current market value of a share with current consensus earnings forecasts, allowing for a real-time assessment of whether an asset is fundamentally overbought or undervalued. By analyzing the projected P/E of Rallybio Corporation (RLYB) on GURU.Markets, an investor can distinguish market noise from actual value growth for Rallybio Corporation (RLYB), given that patent protection for orphan drugs guarantees high margins upon the successful completion of clinical trials.

Pesaing langsung

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SXTC|Pangali Forward P/E Eupraxia Pharma (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences Inc. BHST|EXOZ - Prakiraan rega marang bathi|ORMP: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi abvcpharma.com (ABVC)|Rega marang bathi mangsa ngarep Cumberland Pharma|Rega marang bathi mangsa ngarep QNTM|Pangali Forward P/E FGEN|TELO (Telomir Pharma) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Rani Therapeutics Holdings RANI|SNYR - Prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP